{"name":"Cerebral","slug":"cerebral","ticker":"PRIVATE","exchange":"Private","domain":"cerebral.com","description":"Cerebral is a digital mental health company that offers online therapy and medication management services. Their top products include online therapy sessions and medication management. Cerebral operates in the digital health sector, focusing on mental health. As a private company, Cerebral does not publicly disclose financial information, but it has received significant funding from investors.","hq":"San Francisco, CA","founded":0,"employees":"","ceo":"David Mou","sector":"Digital Health — Mental Health","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$1.2B (last valuation, significantly down from $4.8B peak)","metrics":{"revenue":200000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2022-05-10","type":"deal","headline":"Cerebral Raises $300M in Series C Funding","summary":"Cerebral, a digital mental health company, raised $300 million in Series C funding, bringing its total funding to over $1 billion.","drugName":"","sentiment":"positive"},{"date":"2022-03-01","type":"regulatory","headline":"Cerebral Expands into New Markets with Telehealth Expansion","summary":"Cerebral, a digital mental health company, expanded its services into new markets, allowing patients to access online therapy and medication management services remotely.","drugName":"","sentiment":"neutral"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNZE5zQ2tId1p6VUd4Y0V6X21qdEtCOWg4UHlpN2JrcFJZaUhyZ0pRLVRVZ3J3Sm4yY01fZEtVcjRza0ZFZnhaWjNRZFVYcGU3UkJ2WTdzUU8wcW4wTUY2OXdONnNGel9QZlFSWmF3SkNrWHpyallIZC1DM1cyYm5BanFyVS0zRV9uYTJEMTlfc2VCcTZRNTZtRUc0cERSM1diUlROVHYwSjk?oc=5","date":"2025-09-18","type":"deal","source":"Fierce Pharma","summary":"After buyout, bluebird bio hatches familiar new branding as Genetix Biotherapeutics - Fierce Pharma","headline":"After buyout, bluebird bio hatches familiar new branding as Genetix Biotherapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxOd1o0VUlzY3FsTXQ0VjRxaUwtd3VwZU8yalB5SGJzQ0hnQXFSek1ZRzRuZi1HLTlyb1NKM1Fvd1o5SXo5QzMxYXNYVDVucTRvT1BTMDI2Q09DaURHc3B5T2VRRndsWnNtUjQ1LTBQamFhTEZQV2l4U0QyRW9GU0JtLURkZG9vcmlQbUZRQ3ptdlVVekt4ZXJyRXRDaHcyb1JKcG9VbHZrSHU2a2RfRVB0RFR5b05HWnF6MEpLeEprRS1hbnpKV3BJdUlHVGgyMEk2S0dDZEpPc29iLXZjSmZycWZEdjBnY0FjSEF6V3RrRjdqVXlxY0RRZ1pJWldkZWM?oc=5","date":"2025-06-11","type":"pipeline","source":"GlobeNewswire","summary":"Pharmazz Inc. Secures $25 Million Strategic Equity Investment from Sun Pharmaceutical Industries Ltd. - GlobeNewswire","headline":"Pharmazz Inc. Secures $25 Million Strategic Equity Investment from Sun Pharmaceutical Industries Ltd.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPUkQzaVVPNVY0TGlFRHByM1haakxsc2pFYlJMc2p4TFA5aWR6a3dHZHhrelJuLVNuNVBzY2VTa2wyY3NGejZTc0VJbkthZ0E4RXJFajRWdGFzZTUwLWQ1WnB5aHhpbnRCckRXQURpWk8zWkdhTzNsY1BZZ2xyOGh2U3ZLYlIyY0xTRnBKM0JZaVgzeUs2UVVoTDdmRmFJWXZWTk1SMVZJeUtLbVZyNGpJ?oc=5","date":"2025-05-30","type":"pipeline","source":"Fierce Pharma","summary":"After holding out, bluebird bio investors get on board with sale to Carlyle, SK Capital - Fierce Pharma","headline":"After holding out, bluebird bio investors get on board with sale to Carlyle, SK Capital","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQcFVJUUFtUlc0LWJwX3EzU2JISXkyQi1xcDdXUnkwY1hkQ1cwSjN3ZzlZc0Y1RDBJYnV5LTVJelZHRVkyX3dxTEdfMGM3Mk9uV0hIUHRFcmR5OGVTRzBlV0RwMl9HemJTUUdKX3JzTmliLUlpU2ItUWlPSW4zTDdwV05VTWNZcmxzOWN1NFNiWGhucHluNm5F?oc=5","date":"2025-04-26","type":"pipeline","source":"The People's Pharmacy","summary":"Show 1428: The Hidden Power of the Unconscious Brain - The People's Pharmacy","headline":"Show 1428: The Hidden Power of the Unconscious Brain - The People's Pharmacy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOY1V5WWJjbk42Yl9BeFdpSm0tNTR5cXp4NTJob0JUOTNKOEwzVmExWVRkRWhXVnNBWFdUeFlDX0ZvVEtKNFFISnowaVVwcjhPYzcxb3BlaEtlOU9EQ29jQ2pSV0Zwb2ZhX2xnaC1rZEVEU242YmdTUWQxeExONGxndkdPQkFYTkFBa0pKbGR0dFpWVW9UUnV0UWs0b1ZRdVgyTzN4U1NB?oc=5","date":"2025-02-21","type":"pipeline","source":"Pharmaceutical Technology","summary":"Struggling bluebird bio to go private for less than $30m - Pharmaceutical Technology","headline":"Struggling bluebird bio to go private for less than $30m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOYjZHYU5JSlpwRXRORWZuRVkzbldnZWxwOVNjSnFqN1Mta2FNVHNZbUF2Y1pVRzBfdVk1alpINDl3YlZjd0NNSEdKcjMtZnpaTjRRRUluc1BwN0V0bHNsTHY1RDJaMm1IUDFOdUozZjBDYmx1ZUQ0U2hDTTZubHdON1d3MWdfbTB5RjN5LVFB?oc=5","date":"2025-02-21","type":"deal","source":"BioPharma Dive","summary":"Bluebird, at risk of default, agrees to take-private deal - BioPharma Dive","headline":"Bluebird, at risk of default, agrees to take-private deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBKN3Bwb3MxSXE1TFdmaXJOZkU0WF9hdk0yanF4WlZqVVNVSjhIcGRRNDQxcjRndFZHcWk1SmhqczNJc0VSZ0RsbGNDOHdJR2tFS3Bj?oc=5","date":"2025-02-21","type":"pipeline","source":"FirstWord Pharma","summary":"Cash-strapped bluebird bio to be sold for less than $30M upfront - FirstWord Pharma","headline":"Cash-strapped bluebird bio to be sold for less than $30M upfront","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOZjNHUDZuUmpodXgxcWNsd1RDN1g5WGVkdnR4bWVhTFFka19SMVZkV0ZEOHIwcmpQbG5RMlV4bGpMd284WmdVOWNPb3pndkdYejk5aF91S1p4QmZPclZvS19xc1FSS2c4LXRGWUVIeUFNS0VnY25ETE8xRUc3b2Zyc0lQSWo3NTFPQk4tTXAzcUNSQjR6?oc=5","date":"2025-02-21","type":"pipeline","source":"The Pharma Letter","summary":"Private equity firms rescue bluebird bio out of its misery - The Pharma Letter","headline":"Private equity firms rescue bluebird bio out of its misery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNc1h5QXRiSHM2alRtVTFxaDhRbXJTMGVtYVdUSWpaeFNxdW1JZzZ1MDc4aTlvcF9IRmRYSjBnSFNQWGwtVHctZDJVLV9WX1A2RklTSHJlME1zYjcwTk5CcFMyTGxBNDByWGdnNnRnRkIzSUpRUWJEdXRRRXdtRHE3U1VUQQ?oc=5","date":"2024-11-12","type":"trial","source":"The New York Times","summary":"What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials (Published 2024) - The New York Times","headline":"What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials (Published 2024)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNbldtY3A4bGp0UGQ3dkdEcGU4TEd5QVNrekdTSHk4QUJhOUJzMXFmZzd4ajIzWmFISmJEc1FzTXhYS2stTWc3SE9lQTB1bzNWYkpHWnhqNlRvZWVhbDAzQXA2eFVOOXZyVWViazRTTkNsNkRKcy1HYlo2WWZJTFRrLXlOUlN5ZU51UUZCRmxJN3NuNTV6WXg3MWgwb1MzS1VwVW9ULVc1UDU?oc=5","date":"2024-03-12","type":"pipeline","source":"The University of Rhode Island","summary":"Research report: Pharmacy professors attract millions in research grants - The University of Rhode Island","headline":"Research report: Pharmacy professors attract millions in research grants","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxPcGlOazNXRzM0RnJ0TjJFOHBFbmNQY09GcHQ1SXR5N1BoX21ad1AtbGZjWGUyT2F6c21pNzNzeEFKRExyWXFjWjl6ZG96SkpINzJpbjc4LWY2eEdWNFc4RWRwaVRiOFhKRl92TFhRZWFfQmIwNlRVU0pDWjdIYlgwTk81dFdFQXhqdk0talFiRHdRc1JXWkNBd09meFE4SkwycHR0SEtCc2hZbE01a2sxTGZBczZCanpoWTdFM29TdS1xaEs0SmpXRE5ReHZPLVZ2WTlibWtn?oc=5","date":"2023-11-06","type":"deal","source":"Cardiovascular Business","summary":"Private equity-backed pharmaceutical company acquires stroke drug from Bayer - Cardiovascular Business","headline":"Private equity-backed pharmaceutical company acquires stroke drug from Bayer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxNdmNCYl9nMWpYYlZZWTZCRmxORXVPYjl1UW1WaDVYVFVEQ1MzTy1VNU1fU1RDVGZub1I1S0hrVC1mX01lM3VlYkR5ZTVVcjJQdUtlSHpzU0xfYk5ROGItcUZVaDZiMXhRU2h4V0hmV2N1eUU1dVIyLXR0OXVwLW9ONDJ2OWdGMnNxS3Zzd0dscjMxMmo3bS1VdC0zWENBWkFyUmxtcmxyT1o3QnVDdnlfd0ZhRmxqTXlaQWVLaDhzaFpjX0dJVWZQTWdMam5vVnM?oc=5","date":"2022-05-02","type":"pipeline","source":"WSJ","summary":"Exclusive | Cerebral’s Preferred Pharmacy Truepill Halts Adderall Prescriptions for All Customers - WSJ","headline":"Exclusive | Cerebral’s Preferred Pharmacy Truepill Halts Adderall Prescriptions for All Customers","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["BetterHelp","Talkspace","Amwell"],"therapeuticFocus":["Mental Health","Anxiety","Depression"],"financials":null,"yahoo":null}